Litholink Corporation was founded by Dr. Fredric L. Coe, a professor of medicine at the University of Chicago in 1996. Over the course of his career and through hundreds of research papers, Dr. Coe helped establish the standard of care in kidney stone prevention, chairing the Consensus Conference of the National Institutes of Health (NIH). Litholink was founded to bring Dr. Coe’s life’s work to doctors and their patients across the country. Litholink serves many of the country’s leading urologist and academic medical centers. In 2006, Litholink was acquired by Laboratory Corporation of America Holdings. Litholink continues to be the leader in kidney stone testing and is now applying the Litholink programmatic approach to build comprehensive programs for chronic disease.